Marianne Romeo
Corporate Officer/Principal at MYOVANT SCIENCES LTD.
Marianne Romeo active positions
| Companies | Position | Start | End |
|---|---|---|---|
| MYOVANT SCIENCES LTD. | Corporate Officer/Principal | - | - |
| Bermuda Society For Healthcare Risk Management | Director/Board Member | - | - |
Career history of Marianne Romeo
Former positions of Marianne Romeo
| Companies | Position | Start | End |
|---|---|---|---|
| ROIVANT SCIENCES LTD. | Corporate Officer/Principal | - | 2023-03-31 |
| Bowring Marsh (Bermuda) Ltd. | Chief Executive Officer | 2002-12-31 | 2013-12-31 |
Roivant Sciences GmbH
 Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 2014-02-28 | - |
| SIO GENE THERAPIES INC. | Director/Board Member | 2015-02-28 | - |
| Corporate Officer/Principal | 2015-02-28 | - |
Training of Marianne Romeo
| Hunter College | Graduate Degree |
| Tufts University | Undergraduate Degree |
Statistics
International
| United States | 4 |
| United Kingdom | 3 |
| Bermuda | 3 |
Operational
| Corporate Officer/Principal | 4 |
| Director/Board Member | 2 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ROIVANT SCIENCES LTD. | Health Technology |
| Private companies | 5 |
|---|---|
Roivant Sciences GmbH
Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Health Technology |
Sio Gene Therapies, Inc.
 Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Sio Gene Therapies, Inc. is a clinical-stage biopharmaceutical company, which engages in the acquisition, development, and commercialization of gene therapies for neurological diseases. The company was founded on October 31, 2014 and is headquartered in New York, NY. | Health Technology |
| Bermuda Society For Healthcare Risk Management | |
| Bowring Marsh (Bermuda) Ltd. | |
Myovant Sciences Ltd.
 Myovant Sciences Ltd. BiotechnologyHealth Technology Myovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapies for the treatment of women's health and endocrine diseases. It offers ORGOVYXTM, an oral gonadotropin-releasing hormone (GnRH) receptor antagonist for the treatment of adult patients with advanced prostate cancer, and MYFEMBREE, which is taken for the management of heavy menstrual bleeding associated with uterine fibroids. The company was founded on February 2, 2016 and is headquartered in London, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Marianne Romeo
- Experience
